A. Korn
Impact in
-
- Diabetes Management and Research
- Diabetes Treatment and Management
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Treatment of Major Depression
Papers in
- Physiology 19
- Nitric Oxide and Endothelin Effects 6
- Diet and metabolism studies 5
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 6
- Antibiotics Pharmacokinetics and Efficacy 4
- Co-authors
- S. Gasić (23 shared papers)P. Nowotny (7 shared papers)P. Bratusch-Marrain (8 shared papers)W. Waldhäusl (10 shared papers)H G Eichler (10 shared papers)V. Malerczyk (7 shared papers)G Kleinberger (2 shared papers)Karl‐Heinz Lehr (4 shared papers)
- Journals
- European Journal of Clinical Pharmacology (4 papers)Clinical Pharmacology & Therapeutics (4 papers)Diabetologia (3 papers)British Journal of Clinical Pharmacology (3 papers)Journal of Cardiovascular Pharmacology (2 papers)
- Partner nations
- AustriaGermanySwitzerland
In The Last Decade
A. Korn
63 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Endocrinology, Diabetes and Metabolism 351
- Pharmacology 220
- Biological Psychiatry 23
- Physiology 239
- Neurology 117
Countries citing papers authored by A. Korn
This map shows the geographic impact of A. Korn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Korn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Korn more than expected).
Fields of papers citing papers by A. Korn
This network shows the impact of papers produced by A. Korn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Korn. The network helps show where A. Korn may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Korn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1979 | 134 | |
| 2 | 1979 | 104 | |
| 3 | 1982 | 72 | |
| 4 | 1991 | 68 | |
| 5 | Tyramine pressor effect in man: studies with moclobemide, a novel, reversible monoamine oxidase inhibitor. | 1988 | 54 |
| 6 | 1991 | 47 | |
| 7 | 1982 | 46 | |
| 8 | 1994 | 43 | |
| 9 | 1988 | 42 | |
| 10 | 1986 | 42 | |
| 11 | 1975 | 36 | |
| 12 | 1994 | 36 | |
| 13 | 1986 | 32 | |
| 14 | 1985 | 29 | |
| 15 | 1990 | 27 | |
| 16 | 1992 | 25 | |
| 17 | 1986 | 25 | |
| 18 | 1986 | 25 | |
| 19 | 1996 | 21 | |
| 20 | 1989 | 21 |
About A. Korn
A. Korn is a scholar working on Physiology, Pharmacology, Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology, having authored 67 papers that have together received 1.2k indexed citations. Recurring topics across this work include Diabetes Management and Research (7 papers), Diabetes Treatment and Management (7 papers), Nitric Oxide and Endothelin Effects (6 papers), Pharmacogenetics and Drug Metabolism (6 papers), Diet and metabolism studies (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Pharmaceutical studies and practices (4 papers) and Analytical Methods in Pharmaceuticals (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (351 citations), Pharmacology (220 citations), Biological Psychiatry (23 citations), Physiology (239 citations) and Neurology (117 citations). A. Korn has collaborated with scholars based in Austria, Germany and Switzerland. Frequent co-authors include S. Gasić, P. Nowotny, P. Bratusch-Marrain, W. Waldhäusl, H G Eichler, V. Malerczyk, G Kleinberger, Karl‐Heinz Lehr, W Waldhäusl and M. Badian. Their work appears in journals such as European Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Diabetologia, British Journal of Clinical Pharmacology and Journal of Cardiovascular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.